Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-24,247
Closed -$66.2K 1100
2026
Q1
$66.2K Buy
24,247
+123
+0.5% +$255 ﹤0.01% 996
2025
Q4
$48.2K Sell
24,124
-4,062
-14% -$8.94K ﹤0.01% 993
2025
Q3
$55.2K Buy
+28,186
New +$45.9K ﹤0.01% 998
2025
Q2
Sell
-26,120
Closed -$30.3K 1021
2025
Q1
$30.3K Buy
26,120
+480
+2% +$804 ﹤0.01% 901
2024
Q4
$53.6K Buy
+25,640
New +$48.6K ﹤0.01% 874

Other funds holding GEVO

Ballentine Partners's GEVO Position: Q2 2026 in Review

Ballentine Partners sold out of Gevo (GEVO) in Q2 2026, closing a stake of 24,247 shares — an estimated $66.2K sold.

Ballentine Partners first reported a position in GEVO in Q4 2024 and held it in 5 quarters. The position peaked at $66.2K in Q1 2026. 147 funds tracked by Wall St. Rank hold GEVO as of Q2 2026.

  • Ballentine Partners reported no remaining Gevo position as of Q2 2026 after selling out during the quarter.
  • Ballentine Partners sold 24,247 Gevo shares in Q2 2026, an estimated $66.2K.
  • Ballentine Partners first reported a position in Gevo in Q4 2024 and held it in 5 quarters.
  • Ballentine Partners's Gevo position peaked at $66.2K in Q1 2026.
  • 147 funds tracked by Wall St. Rank held Gevo as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.